Part 5/8:
While the pharmaceutical industry is often considered more insulated from tariff implications, it still faces unique challenges. The sector is characterized by its inelastic demand; however, proposed tariffs could disrupt operations and impact healthcare economics, including Medicare and Medicaid systems. This presents a complex landscape for pharmaceutical companies, requiring them to adapt their strategies to navigate potential tariff implications effectively.